ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
6,040.04
1.10%
Dow Jones
43,297.03
0.91%
US Dollar vs MXN
20.165
-0.02%
Brent Oil
73.285
0.00%
Bitcoin
98,659.32
-0.02%
Pepperstone
Advertisement
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NYSE

  6. Taro Pharmaceutical Industries Ltd (TARO) Cotización

Taro Pharmaceutical Industries Ltd

Taro Pharmaceutical Industries Ltd (TARO)

NYSE
42.97
0.00
(0.00%)
Cerrado 25 Diciembre 3:00PM
Delayed by 15 minutes
0.00
0.00
(0.00%)
Fuera de horario: -
Delayed by 15 minutes

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Premium

Estadísticas y detalles clave

Último Precio
42.97
Postura de Compra
-
Postura de Venta
-
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
0.00 Rango de 52 semanas 0.00
Capitalización de Mercado [m]
1.615B
Precio Anterior
42.97
Precio de Apertura
-
Hora
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
-
Acciones en circulación
37,580,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
29.98
Beneficio por acción (BPA)
1.43
turnover
629.18M
Beneficio neto
53.87M

Acerca de Taro Pharmaceutical Industries Ltd

Taro Pharmaceutical Industries Ltd produces, researches, develops, and markets pharmaceutical products. Its primary focus includes semi-solids formulations, such as creams and ointments and other dosage forms such as liquids, capsules, and tablets. The company is engaged in the dermatological and to... Taro Pharmaceutical Industries Ltd produces, researches, develops, and markets pharmaceutical products. Its primary focus includes semi-solids formulations, such as creams and ointments and other dosage forms such as liquids, capsules, and tablets. The company is engaged in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada, Israel, and Other Countries. Mostrar más

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
www.taro.com
Sede
Haifa, North, Isr
Fundado
-

TARO Últimas noticias

Más noticias

Taro Shareholders Approve Merger with Sun Pharma

Taro Shareholders Approve Merger with Sun Pharma PR Newswire MUMBAI, India and NEW YORK, May 23, 2024 MUMBAI, India and NEW YORK, May 23, 2024 /PRNewswire/ -- Sun Pharmaceutical Industries...

23 Mayo 2024
PR Newswire (US)

Form SC 13E3/A - Going private transaction by certain issuers: [Amend]

23 Mayo 2024
Edgar (US Regulatory)

Taro Shareholders Approve Merger with Sun Pharma

Taro Shareholders Approve Merger with Sun Pharma PR Newswire MUMBAI, India and NEW YORK, May 23, 2024 MUMBAI, India and NEW YORK, May 23, 2024 /PRNewswire/ -- Sun Pharmaceutical Industries...

23 Mayo 2024
PR Newswire (US)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

23 Mayo 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

21 Mayo 2024
Edgar (US Regulatory)

Taro Provides Results for Year Ended March 31, 2024

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and year ended March 31, 2024. Quarter ended March 31, 2024...

20 Mayo 2024
Business Wire

Taro to Release Full Year Results on May 20, 2024

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for year ended March 31, 2024, after the close of market on Monday, May 20, 2024...

15 Mayo 2024
Business Wire

Form SC 13E3/A - Going private transaction by certain issuers: [Amend]

14 Mayo 2024
Edgar (US Regulatory)

Form SC 13E3/A - Going private transaction by certain issuers: [Amend]

08 Mayo 2024
Edgar (US Regulatory)

Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Taro Shareholders Vote “FOR” Taro Sun Pharma Merger

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today announced that leading independent proxy advisory firms Institutional Shareholder Services (“ISS”) and Glass Lewis...

08 Mayo 2024
Business Wire
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

TARO - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Taro Pharmaceutical Indu...?
El precio actual de las acciones de Taro Pharmaceutical Indu... es US$ 42.97
¿Cuántas acciones de Taro Pharmaceutical Indu... están en circulación?
Taro Pharmaceutical Indu... tiene 37,580,000 acciones en circulación
¿Cuál es la capitalización de mercado de Taro Pharmaceutical Indu...?
La capitalización de mercado de Taro Pharmaceutical Indu... es USD 1.61B
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Taro Pharmaceutical Indu...?
Taro Pharmaceutical Indu... ha negociado en un rango de US$ 0.00 a US$ 0.00 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Taro Pharmaceutical Indu...?
El ratio precio/beneficio de Taro Pharmaceutical Indu... es 29.98
¿Cuál es el ratio de efectivo a ventas de Taro Pharmaceutical Indu...?
El ratio de efectivo a ventas de Taro Pharmaceutical Indu... es 2.57
¿Cuál es la moneda de reporte de Taro Pharmaceutical Indu...?
Taro Pharmaceutical Indu... presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Taro Pharmaceutical Indu...?
El último ingresos anual de Taro Pharmaceutical Indu... es USD 629.18M
¿Cuál es el último beneficio anual de Taro Pharmaceutical Indu...?
El último beneficio anual de Taro Pharmaceutical Indu... es USD 53.87M
¿Cuál es la dirección registrada de Taro Pharmaceutical Indu...?
La dirección registrada de Taro Pharmaceutical Indu... es 14 HAKITOR STREET, PO BOX 10347, HAIFA BAY, HAIFA, NORTH, 2624761
¿Cuál es la dirección del sitio web de Taro Pharmaceutical Indu...?
La dirección del sitio web de Taro Pharmaceutical Indu... es www.taro.com
¿En qué sector industrial opera Taro Pharmaceutical Indu...?
Taro Pharmaceutical Indu... opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
MPLNChurchill Capital Corp III
US$ 12.24
(94.90%)
2.11M
NEUENeuehealth Inc
US$ 7.54
(74.94%)
780.07k
SESSES AI Corporation
US$ 0.71
(36.33%)
48.69M
KOREKORE Group Holdings Inc
US$ 1.88
(27.89%)
297.19k
EVTLVertical Aerospace Ltd
US$ 8.96
(20.75%)
286.9k
VNCEVince Holding Corp
US$ 4.00
(-20.00%)
409.69k
DNMRDanimer Scientific Inc
US$ 3.23
(-15.22%)
123.46k
CDR-BCedar Realty Trust Inc
US$ 14.0301
(-10.34%)
8.45k
WSO.BWatsco Inc
US$ 489.70
(-8.47%)
11
MOGUMOGU Inc
US$ 2.18
(-8.02%)
3.55k
QBTSD Wave Quantum Inc
US$ 7.95
(-2.45%)
51.47M
BBAIBigBear ai Holdings Inc
US$ 3.73
(16.93%)
49.68M
SESSES AI Corporation
US$ 0.71
(36.33%)
48.69M
ACHRArcher Aviation Inc
US$ 10.80
(15.14%)
48.49M
FFord Motor Company
US$ 10.02
(1.21%)
29.1M

Discusión

Ver feed completo
rodman rodman 4 minutos hace
Merry Christmas longs!
BIEL
JSmith5 JSmith5 7 minutos hace
"Markets can remain irrational longer than you can remain solvent". - John Maynard Keynes"

I've always regarded Bradford as the poster child for this famous quote.

Nats
FNMA
Monroe1 Monroe1 8 minutos hace
https://m3.gab.com/media_attachments/59/1a/1f/591a1f4955dfe351d818c6853909918b.webp?width=568
PFE
beholder_23 beholder_23 8 minutos hace
No, with confirmation this goes nowhere. They have no money, no engineers, no employees, no talent of any kind, and no experience in the processing of brine.

The equipment necessary to perform DLE is more expensive than the land they own. Not to mention they don't have any employees.
BLTH
Seminole Red Seminole Red 8 minutos hace
an a Merry Christmas to you to
Seminole Red Seminole Red 9 minutos hace
Bill Bergey, the hard-nosed Philadelphia Eagles linebacker who epitomized the NFL's gritty 1970s mystique, has passed away at age 79, according to his family.

The South Dayton, New York native's death was revealed by his son Jake Bergey, a former professional lacrosse player.
pos_stock_hoarder pos_stock_hoarder 11 minutos hace
Merry Christmas, Excel!

It's always nice to see that story this time of year!
Dontnosheet Dontnosheet 11 minutos hace
Merry Christmas everyone!!!
VPLM
JSmith5 JSmith5 13 minutos hace
You must be right, of course, as its in bold.

Nats
FNMA
exostatic exostatic 13 minutos hace
Merry Christmas to all and to all I wish you a great day!!!!
EXO
COOP
exostatic exostatic 14 minutos hace
Merry Christmas to all and to all I wish you a great day!!!!
EXO
FNMA
i_like_bb_stock i_like_bb_stock 14 minutos hace
Merry Christmas!
konshe konshe 15 minutos hace
Tomorrow I will sell all my shares for tax cut
STAL
bigrun bigrun 15 minutos hace
1$+
LITM
LWLG-Netherlands LWLG-Netherlands 17 minutos hace
This dude, keeps attacking but no ban? He clearly doesn’t know anything and is clearly here to bash. Jeeezzz how sad is that! I feel sorry for you. Must be loneliness or something…Hope you get better soon
LWLG
Stock_Barber Stock_Barber 18 minutos hace
It would only be a Fool that would think this no company fraud has shorts.
And only a LIAR or a FOOL that would make the claim that it actually has shorts!
CRSM
totffe totffe 19 minutos hace
You are now on ignore
QNCCF
chemist72 chemist72 19 minutos hace
The 2 most obvious fraudulent statements from MVNT occurred back in 2019.
These statements are quoted below along with a link to the PR from which they came:
Mr. Linh Nguyen, LTN Capital's CEO, stated, “We are extremely excited to add Velocity to our family of companies. With 2018 reve
MVNT
Truthsocial Truthsocial 20 minutos hace
Why I've been posting for months maybe a year Mayo clinic and Dr Korenko with RDGL Human clinical trials soon enough imo ...I was ridiculed etc lol

Here we are kickn the doors down on cancer
RDGL
$5.95akadawson-m $5.95akadawson-m 20 minutos hace
Check it out guys and gals:
https://www.yahoo.com/finance/news/elon-musks-xai-raises-6-105243107.html


The big compute competition is on our doorstep!
IONQ
236T568 236T568 20 minutos hace
Shameful

https://bsky.app/profile/mollyjongfast.bsky.social/post/3le34faeq3c23
manibiotech manibiotech 21 minutos hace
Again , that is you are taking a position of superiority by self- deciding ( self proclaiming) that you are ethical and any long for a decade or more who is critical is a paid basher . 
But it will be a hard concept for you to grasp 

NWBO
Hoskuld Hoskuld 25 minutos hace
The company needs to move on these indications because every day burns up 2-73 patent protection.
AVXL
Preciouslife1 Preciouslife1 25 minutos hace
https://www.facebook.com/share/v/1B7YkF8pNX/?mibextid=wwXIfr

Su Consulta Reciente

NYSE
TARO
Taro Pharmaceutical Indu...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados